APOE and Alzheimer disease: Brain glucose metabolism, measured by fluorodeoxyglucose-positron emission tomography (PET), was reduced in the brain of subjects with AD [22], those with MCI [23] and carriers of the apolipoprotein E epsilon-4 (ApoE4) allele, a major genetic risk factor for late-onset AD [4].